Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Leukemia 41Myelodysplastic Syndromes 35Lymphoma, Non-Hodgkin 17Recurrence 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Lymphocytic, Chronic, B-Cell 11Hodgkin Disease 11Congenital Abnormalities 11Lymphoma 10Leukemia, Myelomonocytic, Chronic 10Hematologic Neoplasms 8Leukemia, Biphenotypic, Acute 7Neoplasms 6Multiple Myeloma 6Leukemia, Myelomonocytic, Juvenile 6Burkitt Lymphoma 6Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Graft vs Host Disease 5Anemia, Refractory, with Excess of Blasts 5Lymphoma, Mantle-Cell 4Lymphoma, B-Cell 4Leukemia, Promyelocytic, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Eosinophilic, Acute 4

Interventions

merphos 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Flow Cytometry 2Cytogenetic Analysis 2Cytarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1adavosertib 1Whole-Body Irradiation 1Sirolimus 1Pharmacogenomic Testing 1Mycophenolic Acid 1In Situ Hybridization, Fluorescence 1Enzyme-Linked Immunosorbent Assay 1Deferasirox 1Cyclosporine 1Clofarabine 1Azacitidine 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chromosome 5q Deletion Syndrome × Clofarabine × Clear all
NCT00839982 2017-07-11

Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDS

Fred Hutchinson Cancer Center

Phase 1/2 Completed
35 enrolled 11 charts
Other hematologic neoplasm

Chromosome 5q Deletion Syndrome, Congenital Abnormalities, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡